JP Morgan Upgrades Cooper Companies: Here's What You Need To Know
JP Morgan Upgrades Cooper Companies: Here's What You Need To Know
JP Morgan upgraded its rating of Cooper Companies (NASDAQ:COO) to Overweight with a price target of $120.00, changing its price target from $100.00 to $120.00.
摩根大通將其對庫珀公司（納斯達克股票代碼：COO）的評級上調至增持，目標股價爲120.00美元，將其目標股價從100.00美元上調至120.00美元。
Shares of Cooper Companies are trading up 1.88% over the last 24 hours, at $103.45 per share.
庫珀公司的股價在過去24小時內上漲了1.88％，至每股103.45美元。
A move to $120.00 would account for a 16.0% increase from the current share price.
升至120.00美元將導致當前股價上漲16.0％。
About Cooper Companies
關於庫珀公司
The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.
庫珀公司是美國最大的眼部護理公司之一，分爲兩個部門：CooperVision和CooperSurgical。CooperVision是一家純粹的隱形眼鏡企業，由一系列球面、多焦點和復曲面隱形眼鏡組成。該公司還擁有世界上最全面的特種鏡頭產品組合之一。庫珀擁有包括Proclear、Biofinity、MyDay和clariti在內的品牌，控制着大約四分之一的美國隱形眼鏡市場。CooperSurgical成立於1990年，由與生殖保健、生育和女性護理相關的設備組成。在整個試管嬰兒週期中，庫珀擁有最廣泛的醫療器械覆蓋範圍。它還擁有Paragard，這是美國唯一的無激素宮內節育器，控制着美國宮內節育器市場的17％。
About Analyst Ratings
關於分析師評級
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
分析師在銀行和金融系統工作，通常專門研究股票或特定行業的報告。分析師可以參加公司電話會議和會議，研究公司財務報表，並與內部人士溝通，公佈股票的 “分析師評級”。分析師通常每季度對每隻股票進行一次評級。
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
一些分析師還將提供增長預期、收益和收入等指標的預測，以爲股票提供進一步指導。使用分析師評級的投資者應注意，這種專業建議來自人類，可能會出錯。
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along with analyst success scores in Benzinga Pro.
如果您想跟蹤哪些分析師的表現優於其他分析師，可以在Benzinga Pro中查看最新的分析師評級以及分析師成功得分。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。